Late Wednesday, German pharmaceutical CureVac announced what it called “sobering” news about its experimental covid-19 vaccine candidate: In the interim results from a large clinical trial, the vaccine appeared to be only 47% effective. This latest disappointment is a reminder of how lucky the U.S. has been to have…
via Gizmodo